COVID-19 in Pediatric Granulomatosis with Polyangiitis

The confirmed cases with COVID-19 in children account for just 1% of the overall confirmed cases. Severe COVID-19 in children is rare. Case Presentation: Our patient was 16 years old with a severe case of COVID-19 and did not survive due to the presence of Granulomatosis with polyangiitis and being...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Amir, Shorafa, Eslam, Seratishirazi, Zahra, Abootalebi, Seyedenarjes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839039/
https://www.ncbi.nlm.nih.gov/pubmed/33406578
http://dx.doi.org/10.3390/pediatric13010004
_version_ 1783643315102547968
author Saeed, Amir
Shorafa, Eslam
Seratishirazi, Zahra
Abootalebi, Seyedenarjes
author_facet Saeed, Amir
Shorafa, Eslam
Seratishirazi, Zahra
Abootalebi, Seyedenarjes
author_sort Saeed, Amir
collection PubMed
description The confirmed cases with COVID-19 in children account for just 1% of the overall confirmed cases. Severe COVID-19 in children is rare. Case Presentation: Our patient was 16 years old with a severe case of COVID-19 and did not survive due to the presence of Granulomatosis with polyangiitis and being treated with immunosuppressive drugs. We used lopinavir, ritonavir, hydroxy chloroquine, intravenous immunoglobulin and continuous veno-venous hemodialysis for treatment. Conclusion: In this patient, an underlying disease and delayed admission to the hospital were two factors complicating his condition.
format Online
Article
Text
id pubmed-7839039
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78390392021-01-28 COVID-19 in Pediatric Granulomatosis with Polyangiitis Saeed, Amir Shorafa, Eslam Seratishirazi, Zahra Abootalebi, Seyedenarjes Pediatr Rep Case Report The confirmed cases with COVID-19 in children account for just 1% of the overall confirmed cases. Severe COVID-19 in children is rare. Case Presentation: Our patient was 16 years old with a severe case of COVID-19 and did not survive due to the presence of Granulomatosis with polyangiitis and being treated with immunosuppressive drugs. We used lopinavir, ritonavir, hydroxy chloroquine, intravenous immunoglobulin and continuous veno-venous hemodialysis for treatment. Conclusion: In this patient, an underlying disease and delayed admission to the hospital were two factors complicating his condition. MDPI 2021-01-04 /pmc/articles/PMC7839039/ /pubmed/33406578 http://dx.doi.org/10.3390/pediatric13010004 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Saeed, Amir
Shorafa, Eslam
Seratishirazi, Zahra
Abootalebi, Seyedenarjes
COVID-19 in Pediatric Granulomatosis with Polyangiitis
title COVID-19 in Pediatric Granulomatosis with Polyangiitis
title_full COVID-19 in Pediatric Granulomatosis with Polyangiitis
title_fullStr COVID-19 in Pediatric Granulomatosis with Polyangiitis
title_full_unstemmed COVID-19 in Pediatric Granulomatosis with Polyangiitis
title_short COVID-19 in Pediatric Granulomatosis with Polyangiitis
title_sort covid-19 in pediatric granulomatosis with polyangiitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839039/
https://www.ncbi.nlm.nih.gov/pubmed/33406578
http://dx.doi.org/10.3390/pediatric13010004
work_keys_str_mv AT saeedamir covid19inpediatricgranulomatosiswithpolyangiitis
AT shorafaeslam covid19inpediatricgranulomatosiswithpolyangiitis
AT seratishirazizahra covid19inpediatricgranulomatosiswithpolyangiitis
AT abootalebiseyedenarjes covid19inpediatricgranulomatosiswithpolyangiitis

Ejemplares similares